These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 8425564

  • 1. Potentiation of myeloid colony-formation in bone marrow of intact and neonatally thymectomized mice by the thymic hormone THF-gamma 2.
    Pecht M, Lourie S, Burstein Y, Zipori D, Trainin N.
    Exp Hematol; 1993 Feb; 21(2):277-82. PubMed ID: 8425564
    [Abstract] [Full Text] [Related]

  • 2. THF, a thymic hormone, promotes interleukin-2 production in intact and thymus-deprived mice.
    Umiel T, Pecht M, Trainin N.
    J Biol Response Mod; 1984 Aug; 3(4):423-34. PubMed ID: 6332883
    [Abstract] [Full Text] [Related]

  • 3. Thymic humoral factor-gamma 2 (THF-gamma 2) immunotherapy reduces the metastatic load and restores immunocompetence in 3LL tumor-bearing mice receiving anticancer chemotherapy.
    Ophir R, Pecht M, Keisari Y, Rashid G, Lourie S, Meshorer A, Ben-Efraim S, Trainin N, Burstein Y.
    Immunopharmacol Immunotoxicol; 1996 May; 18(2):209-36. PubMed ID: 8771368
    [Abstract] [Full Text] [Related]

  • 4. Indirect stimulation of hemopoiesis by hemoregulatory peptide (HP5b) dimer in murine long-term bone marrow cultures.
    Veiby OP, Løvhaug D, Fjerdingstad H, Engelsen SJ.
    Exp Hematol; 1992 Feb; 20(2):192-5. PubMed ID: 1544388
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S, Saï P, Bach JM.
    Immunol Lett; 2004 Feb 15; 91(2-3):221-7. PubMed ID: 15019293
    [Abstract] [Full Text] [Related]

  • 7. Increased granulopoiesis after sequential administration of transforming growth factor-beta 1 and granulocyte-macrophage colony-stimulating factor.
    Hestdal K, Jacobsen SE, Ruscetti FW, Longo DL, Boone TC, Keller JR.
    Exp Hematol; 1993 Jun 15; 21(6):799-805. PubMed ID: 8500577
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Homing efficiency and hematopoietic reconstitution of bone marrow-derived stroma cells expanded by recombinant human macrophage-colony stimulating factor in vitro.
    Jin-Xiang F, Xiaofeng S, Jun-Chuan Q, Yan G, Xue-Guang Z.
    Exp Hematol; 2004 Dec 15; 32(12):1204-11. PubMed ID: 15588945
    [Abstract] [Full Text] [Related]

  • 10. The role of a thymus humoral factor in the proliferation of bone marrow CFU-S from thymectomized mice.
    Zipori D, Trainin N.
    Exp Hematol; 1975 Nov 15; 3(6):389-98. PubMed ID: 1104372
    [Abstract] [Full Text] [Related]

  • 11. [Differentiation characteristics of circulating and bone marrow hematopoietic stem cells and the effect of thymus factors].
    Popov BV, Ergakova EV.
    Biull Eksp Biol Med; 1985 May 15; 99(5):610-3. PubMed ID: 3839146
    [Abstract] [Full Text] [Related]

  • 12. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 15; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-4 (IL-4) in combination with IL-11 or IL-6 reverses the inhibitory effect of IL-3 on early B lymphocyte development.
    Neben S, Donaldson D, Fitz L, Calvetti J, Neben T, Turner K, Hirayama F, Ogawa M.
    Exp Hematol; 1996 Jun 15; 24(7):783-9. PubMed ID: 8647228
    [Abstract] [Full Text] [Related]

  • 14. Impaired radioprotective capacity and reduced proliferative rate of bone marrow from neonatally thymectomized mice;
    Zipori D, Trainin N.
    Exp Hematol; 1975 Jan 15; 3(1):1-11. PubMed ID: 1097261
    [Abstract] [Full Text] [Related]

  • 15. In vivo modulation of hematopoiesis by a novel hematoregulatory peptide.
    Pelus LM, King AG, Broxmeyer HE, DeMarsh PL, Petteway SR, Bhatnagar PK.
    Exp Hematol; 1994 Mar 15; 22(3):239-47. PubMed ID: 8112423
    [Abstract] [Full Text] [Related]

  • 16. The effect of recombinant murine interferon-gamma on the hematopoietic and immunological parameters of mice bearing metastatic Lewis lung carcinoma tumors.
    Young MR, Young ME, Wepsic HT.
    Exp Hematol; 1988 May 15; 16(4):295-301. PubMed ID: 2966070
    [Abstract] [Full Text] [Related]

  • 17. The mast cell-committed progenitor. In vitro generation of committed progenitors from bone marrow.
    Ashman RI, Jarboe DL, Conrad DH, Huff TF.
    J Immunol; 1991 Jan 01; 146(1):211-6. PubMed ID: 1898599
    [Abstract] [Full Text] [Related]

  • 18. Increased reactivity of responding cells in the mixed lymphocyte reaction by a thymic humoral factor.
    Umiel T, Trainin N.
    Eur J Immunol; 1975 Feb 01; 5(2):85-8. PubMed ID: 135681
    [Abstract] [Full Text] [Related]

  • 19. Effect of thymic hormone on the response of different lymphoid cell populations to T mitogens.
    Rotter V, Trainin N.
    Isr J Med Sci; 1977 Apr 01; 13(4):363-70. PubMed ID: 301520
    [Abstract] [Full Text] [Related]

  • 20. Leukemia inhibitory factor induces in vivo expansion of bone marrow progenitor cells that accelerate hematopoietic reconstitution but do not enhance radioprotection in lethally irradiated mice.
    Pruijt JF, Lindley IJ, Heemskerk DP, Willemze R, Fibbe WE.
    Stem Cells; 1997 Apr 01; 15(1):50-5. PubMed ID: 9007222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.